Researchers at Stanford have developed methods to enhance bone healing in diabetic patients, who often suffer from impaired fracture healing due to a deficiency in hedgehog signaling in their skeletal stem cells.
Researchers in Prof. Irving Weissman's lab have developed and patented antibodies and methods to prevent the formation of teratomas from human pluripotent stem cells used for regenerative medicine, cell therapy or research.
Mice hemizygous for the MRP8-Cre-ires/GFP transgene are viable and fertile, with the human S100 calcium binding protein A8 (calgranulin A) (MRP8 or S100A8) promoter directing bicistronic Cre and EGFP protein expression to granulocytes and granulocyte/macrophage progenitors (GM
A team of Stanford researchers have identified a skeletal stem cell (SSC) along with the protein factors needed to direct differentiation toward bone, cartilage or bone marrow stroma.
Lab Designation: RB6 8C5; A rat-mouse hybridoma cell line producing a monoclonal IgG2b rat AB which recognizes most, if not all, granuloytes and granolucyte precursors in the mouse bone marrow.
Lab designation: RA3 6B2; A rat-mouse hybridoma cell line producing a monoclonal IgG2a rat AB which recognizes a B cell specific form of the T200 family of cell surface glycoproteins. B220 was first characterized by another MAB, RA3-3A1.
This antibody(MEL-14) is specific for a single class of lymphocyte surface molecules that appear to mediate recognition of lymph node high endothelial venules and that appear to be required for lymphocyte homing to lymph nodes in vivo.